Sort by
Refine Your Search
-
Northeastern University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Apellis Pharmaceuticals is offering a two-year
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Ironwood Pharmaceuticals is offering a two-year Regulatory
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Eidos, a BridgeBio Pharma, Inc. Affiliate, is offering a two
-
faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Takeda is offering a two-year Global Regulatory Affairs- Plasma
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Abbott Diabetes Care is offering a two-year Global Medical
-
with Northeastern University faculty in professional and career development, service, scholarship, and teaching. In partnership with Northeastern University, Chiesi Global Rare Diseases (GRD) is offering
-
faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Takeda Pharmaceutical Company is offering a two-year Global Medical
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Vertex Pharmaceuticals is offering a two-year Medical
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year US Medical
-
University faculty in professional and career development, teaching, service, and scholarly activities. In partnership with Northeastern University, Alnylam Pharmaceuticals is offering a two-year Regulatory